150 related articles for article (PubMed ID: 22086722)
1. Screening, identification, and characterization of mechanistically diverse inhibitors of the Mycobacterium tuberculosis enzyme, pantothenate kinase (CoaA).
Venkatraman J; Bhat J; Solapure SM; Sandesh J; Sarkar D; Aishwarya S; Mukherjee K; Datta S; Malolanarasimhan K; Bandodkar B; Das KS
J Biomol Screen; 2012 Mar; 17(3):293-302. PubMed ID: 22086722
[TBL] [Abstract][Full Text] [Related]
2. Efficient elimination of nonstoichiometric enzyme inhibitors from HTS hit lists.
Habig M; Blechschmidt A; Dressler S; Hess B; Patel V; Billich A; Ostermeier C; Beer D; Klumpp M
J Biomol Screen; 2009 Jul; 14(6):679-89. PubMed ID: 19470716
[TBL] [Abstract][Full Text] [Related]
3. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening.
Segura-Cabrera A; Rodríguez-Pérez MA
Bioorg Med Chem Lett; 2008 Jun; 18(11):3152-7. PubMed ID: 18486472
[TBL] [Abstract][Full Text] [Related]
4. Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition.
Mehra R; Rajput VS; Gupta M; Chib R; Kumar A; Wazir P; Khan IA; Nargotra A
J Chem Inf Model; 2016 May; 56(5):930-40. PubMed ID: 27149193
[TBL] [Abstract][Full Text] [Related]
5. Assay development for identifying inhibitors of the mycobacterial FadD32 activity.
Galandrin S; Guillet V; Rane RS; Léger M; N R; Eynard N; Das K; Balganesh TS; Mourey L; Daffé M; Marrakchi H
J Biomol Screen; 2013 Jun; 18(5):576-87. PubMed ID: 23364516
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel inhibitors targeting the Mycobacterium tuberculosis O-acetylserine sulfhydrylase (CysK1) using virtual high-throughput screening.
Jean Kumar VU; Poyraz Ö; Saxena S; Schnell R; Yogeeswari P; Schneider G; Sriram D
Bioorg Med Chem Lett; 2013 Mar; 23(5):1182-6. PubMed ID: 23391589
[TBL] [Abstract][Full Text] [Related]
7. Structure guided lead generation for M. tuberculosis thymidylate kinase (Mtb TMK): discovery of 3-cyanopyridone and 1,6-naphthyridin-2-one as potent inhibitors.
Naik M; Raichurkar A; Bandodkar BS; Varun BV; Bhat S; Kalkhambkar R; Murugan K; Menon R; Bhat J; Paul B; Iyer H; Hussein S; Tucker JA; Vogtherr M; Embrey KJ; McMiken H; Prasad S; Gill A; Ugarkar BG; Venkatraman J; Read J; Panda M
J Med Chem; 2015 Jan; 58(2):753-66. PubMed ID: 25486447
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Mycobacterium tuberculosis pantothenate kinase vulnerability through target knockdown and mechanistically diverse inhibitors.
Reddy BK; Landge S; Ravishankar S; Patil V; Shinde V; Tantry S; Kale M; Raichurkar A; Menasinakai S; Mudugal NV; Ambady A; Ghosh A; Tunduguru R; Kaur P; Singh R; Kumar N; Bharath S; Sundaram A; Bhat J; Sambandamurthy VK; Björkelid C; Jones TA; Das K; Bandodkar B; Malolanarasimhan K; Mukherjee K; Ramachandran V
Antimicrob Agents Chemother; 2014 Jun; 58(6):3312-26. PubMed ID: 24687493
[TBL] [Abstract][Full Text] [Related]
9. A novel inhibitor of Mycobacterium tuberculosis pantothenate synthetase.
White EL; Southworth K; Ross L; Cooley S; Gill RB; Sosa MI; Manouvakhova A; Rasmussen L; Goulding C; Eisenberg D; Fletcher TM
J Biomol Screen; 2007 Feb; 12(1):100-5. PubMed ID: 17175524
[TBL] [Abstract][Full Text] [Related]
10. Development of a simple high-throughput screening protocol based on biosynthetic activity of Mycobacterium tuberculosis glutamine synthetase for the identification of novel Inhibitors.
Singh U; Sarkar D
J Biomol Screen; 2006 Dec; 11(8):1035-42. PubMed ID: 16973920
[TBL] [Abstract][Full Text] [Related]
11. Identification of shikimate kinase inhibitors among anti-Mycobacterium tuberculosis compounds by LC-MS.
Simithy J; Reeve N; Hobrath JV; Reynolds RC; Calderón AI
Tuberculosis (Edinb); 2014 Mar; 94(2):152-8. PubMed ID: 24429106
[TBL] [Abstract][Full Text] [Related]
12. A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition.
Yang Y; Gao P; Liu Y; Ji X; Gan M; Guan Y; Hao X; Li Z; Xiao C
Bioorg Med Chem Lett; 2011 Jul; 21(13):3943-6. PubMed ID: 21641210
[TBL] [Abstract][Full Text] [Related]
13. Assays, surrogates, and alternative technologies for a TB lead identification program targeting DNA gyrase ATPase.
Humnabadkar V; Madhavapeddi P; Basavarajappa H; Sheikh MG; Rane R; Basu R; Verma P; Sundaram A; Mukherjee K; de Sousa SM
J Biomol Screen; 2015 Feb; 20(2):265-74. PubMed ID: 25300873
[TBL] [Abstract][Full Text] [Related]
14. Structure-based in silico design of a high-affinity dipeptide inhibitor for novel protein drug target Shikimate kinase of Mycobacterium tuberculosis.
Kumar M; Verma S; Sharma S; Srinivasan A; Singh TP; Kaur P
Chem Biol Drug Des; 2010 Sep; 76(3):277-84. PubMed ID: 20626408
[TBL] [Abstract][Full Text] [Related]
15. Structural and biochemical characterization of compounds inhibiting Mycobacterium tuberculosis pantothenate kinase.
Björkelid C; Bergfors T; Raichurkar AK; Mukherjee K; Malolanarasimhan K; Bandodkar B; Jones TA
J Biol Chem; 2013 Jun; 288(25):18260-70. PubMed ID: 23661699
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
17. Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Devi PB; Samala G; Sridevi JP; Saxena S; Alvala M; Salina EG; Sriram D; Yogeeswari P
ChemMedChem; 2014 Nov; 9(11):2538-47. PubMed ID: 25155986
[TBL] [Abstract][Full Text] [Related]
18. A novel high-throughput cellular screening assay for the discovery of HIV-1 integrase inhibitors.
Van Loock M; Meersseman G; Van Acker K; Van Den Eynde C; Jochmans D; Van Schoubroeck B; Dams G; Heyndrickx L; Clayton RF
J Virol Methods; 2012 Feb; 179(2):396-401. PubMed ID: 22172974
[TBL] [Abstract][Full Text] [Related]
19. A high-throughput screening assay for simultaneous selection of inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate synthase (Dxs) or 1-deoxy-D-xylulose 5-phosphate reductoisomerase (Dxr).
Humnabadkar V; Jha RK; Ghatnekar N; De Sousa SM
J Biomol Screen; 2011 Mar; 16(3):303-12. PubMed ID: 21335601
[TBL] [Abstract][Full Text] [Related]
20. High-throughput determination of mode of inhibition in lead identification and optimization.
Wei M; Wynn R; Hollis G; Liao B; Margulis A; Reid BG; Klabe R; Liu PC; Becker-Pasha M; Rupar M; Burn TC; McCall DE; Li Y
J Biomol Screen; 2007 Mar; 12(2):220-8. PubMed ID: 17351185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
